oral semaglutide cardiovascular outcomes soul trial results 2024 2025 New Science Suggests Semaglutide Improves CV Outcomes Beyond Weight Loss Oral Semaglutide's Impact on Cardiovascular

However, recent CVOTs have found the CV benefits after only a few years, indicating that CV complications may be influenced by aspects beyond the traditional risk factors such as HbA 1c [64]

These approaches remain largely experimental and should be discussed with a qualified healthcare provider

Preliminary Research & Related Findings Emerging research though limited and often preliminary suggests plausible biological pathways and associations: 1

Treatment involves long-term systemic antibiotics with appropriate pseudomonal coverage, hyperbaric oxygen, and possibly surgical debridement

2022;45(12):e182e183

Some patients reported developing a flat affect